These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8814476)

  • 21. Overdose of methyldopa, indapamide and theophylline resulting in prolonged hypotension, marked diuresis and hypokalaemia in an elderly patient.
    Chan TY; Gomersall CD; Cheng CA; Woo J
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):977-9. PubMed ID: 19623566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacologic stability of 35-year old theophylline.
    Regenthal R; Stefanovic D; Albert T; Trauer H; Wolf T
    Hum Exp Toxicol; 2002 Jun; 21(6):343-6. PubMed ID: 12195938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
    Gray RJ
    Chest; 1988 Feb; 93(2):398-403. PubMed ID: 2892647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting.
    Arar C; Colak A; Alagol A; Uzer SS; Ege T; Turan N; Duran E; Pamukcu Z
    Eur J Anaesthesiol; 2007 Oct; 24(10):826-31. PubMed ID: 17583595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative use of esmolol.
    Reves JG; Flezzani P
    Am J Cardiol; 1985 Oct; 56(11):57F-62F. PubMed ID: 2864850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esmolol in the treatment of supraventricular tachyarrhythmias.
    Das G; Ferris J
    Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of a new ultra short-acting beta adrenoblocker esmolol in anesthesiological practice].
    Buniatian AA; Trekova NA; Flerov EV; Shitikov II; Poplavskiĭ IV
    Anesteziol Reanimatol; 1993; (3):11-4. PubMed ID: 7943893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of esmolol in the intraoperative management of pheochromocytoma.
    Nicholas E; Deutschman CS; Allo M; Rock P
    Anesth Analg; 1988 Nov; 67(11):1114-7. PubMed ID: 2903700
    [No Abstract]   [Full Text] [Related]  

  • 30. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
    Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
    Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Esmolol attenuation of hemodynamic changes in resuscitation of hypertensive and coronary patients].
    Marty J; Kirsteter P; Cantineau JP; Couderc E; Lefèvre P; Lagoueyte JF; Desmonts JM
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R95. PubMed ID: 2574969
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of a beta-blocker esmolol in patients with acute myocardial infarction treated with streptokinase].
    Shalaev SV; Bukhvalov VA; Petrik ES; Shabalkov EA
    Kardiologiia; 2002; 42(6):4-7. PubMed ID: 12494123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe beta blocker and calcium channel blocker overdose: Role of high dose insulin.
    Seegobin K; Maharaj S; Deosaran A; Reddy P
    Am J Emerg Med; 2018 Apr; 36(4):736.e5-736.e6. PubMed ID: 29331270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia.
    Miller DR; Martineau RJ
    Can J Anaesth; 1989 Sep; 36(5):593-7. PubMed ID: 2571423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of an ultra short-acting adrenergic blocker (esmolol) in patients undergoing coronary artery bypass surgery.
    Harrison L; Ralley FE; Wynands JE; Robbins GR; Sami M; Ripley R; Fullerton HA
    Anesthesiology; 1987 Mar; 66(3):413-8. PubMed ID: 2881505
    [No Abstract]   [Full Text] [Related]  

  • 36. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal theophylline poisoning with rhabdomyolysis. A potential role for dantrolene treatment.
    Parr MJ; Willatts SM
    Anaesthesia; 1991 Jul; 46(7):557-9. PubMed ID: 1862895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised study of perioperative esmolol infusion for haemodynamic stability during major vascular surgery; rationale and design of DECREASE-XIII.
    Bakker EJ; Ravensbergen NJ; Voute MT; Hoeks SE; Chonchol M; Klimek M; Poldermans D
    Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):317-23. PubMed ID: 21632265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autonomic dysfunction and Guillain-Barré syndrome. The use of esmolol in its management.
    Calleja MA
    Anaesthesia; 1990 Sep; 45(9):736-7. PubMed ID: 1978606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina.
    Barth C; Ojile M; Pearson AC; Labovitz AJ
    Am Heart J; 1991 Mar; 121(3 Pt 1):782-8. PubMed ID: 1672051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.